Stock Evaluator: Bumrungrad Hospital Public Company Limited (BUHPY)
Bumrungrad Hospital Public Company Limited BUHPY
$64.00
0.00
0.00%
January 15, 2019 12:00:14 PM
EST
Volume: 0
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
| DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Bumrungrad Hospital Public Company Limited owns and operates hospitals and healthcare centers in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, pediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic, dialysis, radiology and nuclear medicine, digestive disease, ear, nose, throat, emergency, endocrinology, esperance, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopaedics, perinatal, plastic surgery, pulmonary, refractive surgery, memory, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, IVF, hearing and balance, medical, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, and vaccine clinics and centers. In addition, it operates spine institute, heart institute, and intensive care unit; and offers nutrition services, pharmacy services, preventive genomics and integrative medicine services. Bumrungrad Hospital Public Company Limited was founded in 1975 and is based in Bangkok, Thailand.
Financial Summary
| Share Statistics | BUHPY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $4,868.6 | $1,968.0 | 66% |
|
| Shares Out (Mil) | 26.1 | 77.7 | 34% |
|
| Institutional Ownership | 31.8% | 86.6% | 13% |
|
| Float (Mil) | 713.1 | 52.1 | 89% |
|
| Beta | 0.18 | 0.75 | 12% |
|
| Avg Daily Volume (000s) | 0 | 612 | 0% |
|
| Price Change (52-week) |
na | 79.8% | na |
|
| Growth | BUHPY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 14.3% | 10.9% | 71% |
|
| Net Income (5yr) | 42.8% | (1.6%) | 92% |
|
| EPS (5yr) | 43.0% | 0.3% | 90 |
|
| Dividends (5yr) | 8.3% | 0.0% | 61% |
|
| Cash Flow (5yr) | 47.6% | (17.9%) | 93% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | BUHPY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $772 | $1,504 | 47% |
|
| Net Income (TTM) (Mil) | $229 | $28 | 69% |
|
| EPS (TTM) | $0.287 | $0.200 | 49% |
|
| Operating Cash Flow (TTM) (Mil) | $212 | $162 | 60% |
|
| Net Cash Flow (TTM) (Mil) | $64 | $9 | 72% |
|
| Long-Term Debt (Q1) (Mil) | $2 | $338 | 20% |
|
| Enterprise Value (Q1) (Mil) | $4,351 | $2,416 | 60% |
|
| Valuation | BUHPY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.82 | na |
|
| P/E | na | 26.0 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | BUHPY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 52.2% | 27.8% | 64% |
|
| Net Margin | 29.6% | 1.2% | 88% |
|
| ROA | 22.4% | 2.2% | 97% |
|
| ROE | 26.8% | 7.2% | 85% |
|
| Liabilities to Assets | 16.4% | 58.6% | 10% |
|
| F-Score | na | 5 | na |
|
Bumrungrad Hospital Public Company Limited did not pass any screens on 8/21/2026.
